Product Information
TIMOLOL 0.5% EYE DROPS is a generic product labeled by Somerset Therapeutics, LLC, priced at $21.6742 per ML under NDC 70069069601. Its NADAC has been published 59 times since Aug 20, 2025.
FDA first approved this application on Oct 10, 2024. Its Orange Book therapeutic-equivalence code is AT.
Strength
5 mg/mL
Manufacturer
Somerset Therapeutics, LLCNDC
70069069601
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
TIMOLOL ANHYDROUSApproval Type
Generic (ANDA)
FDA Application
ANDA216654FDA Approved
10/10/2024
TE Code
AT
On Market Since
10/31/2024
Pharmacological Classes
Price Statistics
The NADAC for TIMOLOL 0.5% EYE DROPS has been published 59 times since Aug 20, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $21.6742 per ML |
|---|---|
| All-time high | $22.1221 (Aug 12, 2026) |
| All-time low | $20.9693 (Jan 21, 2026) |
| 52-week high | $22.1221 |
| 52-week low | $20.9693 |
| Median price | $21.6620 |
| Average price | $21.5856 |
| Largest weekly change | -1.7% (Nov 19, 2025) |
| Weeks tracked | 59 |
| Tracking since | Aug 20, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Timolol Hemihydrate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Somerset Therapeutics, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Timolol Hemihydrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TIMOLOL 0.5% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for TIMOLOL 0.5% EYE DROPS, manufactured by Somerset Therapeutics, LLC, is $21.6742 per ML (NDC 70069069601), effective Sep 30, 2026.
How has the price of TIMOLOL 0.5% EYE DROPS changed over time?
Over the history we have for it, the NADAC for TIMOLOL 0.5% EYE DROPS has held within roughly two percent of its current level. It has been tracked across 59 weekly CMS publications since Aug 20, 2025.
What are the highest and lowest recorded NADAC prices for TIMOLOL 0.5% EYE DROPS?
Since Aug 20, 2025, the NADAC for TIMOLOL 0.5% EYE DROPS has ranged from a low of $20.9693 (Jan 21, 2026) to a high of $22.1221 (Aug 12, 2026), with a median of $21.6620 per ML.
Are there cheaper alternatives to TIMOLOL 0.5% EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of TIMOLOL 0.5% EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TIMOLOL 0.5% EYE DROPS?
TIMOLOL 0.5% EYE DROPS (NDC 70069069601) is labeled by Somerset Therapeutics, LLC, and CMS classifies it as a generic product.